Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending September 3, 2021

Overall drug TRx are +1.1% w/w

Vascepa
TRx 81,546; +2.3% (+1,825) w/w; -11.5% y/y
NRx 36,584; +1.2% (+449) w/w; -14.7% y/y
Ref 44,962; +3.2% (+1,376) w/w; -8.8% y/y

Lovaza (Generic & Brand)
TRx 63,421; +3.0% (+1,849) w/w; -0.7% y/y
NRx 30,571; +1.4% (+418) w/w; -2.9% y/y
Ref 32,850; +4.6% (+1,431) w/w; +1.4% y/y

Generic Vascepa
TRx 17,511; +4.5% (+755) w/w; As % of total V: 17.5%
NRx 9,910; +2.5% (+238) w/w; As % of total V: 21.3%
Ref 7,601; +7.3% (+517) w/w; As % of total V: 14.5%

Generic Vascepa by Manufacturer
Hikma TRx 12,282 (+756); Generic share 70.1%; Total V share 12.4%
Reddy TRx 5,229 (-1); Generic share 29.9%; Total V share 5.3%